Perindopril tab 2 mg and 4 mg: Brand change

Perindopril is a long-acting ACE inhibitor. Your brand is changing from Apo-Perindopril to Coversyl.

Your new brand: Coversyl

We listed the Coversyl brand from 1 February 2021 to ensure a funded brand remains available as supplies of Apo-perindopril were exhausted at around this time.

Coversyl has the same active ingredient which is delivered to the body in the same way. This product will be supplied under provisional consent.

The Coversyl brand was listed and fully funded from 1 February 2021.

Packaging difference

Coversyl is currently supplied with packaging for the Canadian market. Medsafe have written to health professionals about the differences between the Canadian packaging and New Zealand's requirements.

Read the packaging letter on Medsafe's website (PDF)(external link)  

Apotex leaving the market

As Apotex is leaving New Zealand, we are arranging new suppliers for the medicines they had supplied.

Learn more about Apotex

Apo-Perindopril delisted 1 October 2021

Both presentations of Apo-Perindopril were delisted from the Pharmaceutical Schedule on 1 October 2021.

Who to contact

If you take perindopril, ask your health care professional if you have any questions about this brand change. They know you and your clinical circumstances best. 

If you have any funding questions, email